001     280934
005     20250918102642.0
037 _ _ |a DZNE-2025-01017
100 1 _ |a Herholz, Karl
|0 P:(DE-2719)9001205
|b 0
245 _ _ |a Functional and Molecular Neuroimaging
260 _ _ |c 2021
|b Elsevier
295 1 0 |a Bradley and Daroff's Neurology in Clinical Practice
300 _ _ |a 576 - 600.e10
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1758103396_31852
|2 PUB:(DE-HGF)
490 0 _ |v 1
520 _ _ |a This chapter provides an overview on the diagnostic utility of positron emission tomography (PET), single-photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI) in neurology. PET is now providing essential imaging biomarkers for Alzheimer disease (AD), especially for its early detection and differentiation from other neurodegenerative diseases such as frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB). PET and SPECT also play important roles for the diagnosis of Parkinson disease, focal epilepsy, paraneoplastic encephalitis, and coma. PET can demonstrate metabolic activity of brain tumors and contribute to therapy planning and early detection of recurrent tumors. Increasingly, fMRI, which is still primarily a tool for research, may also support diagnosis of neurodegenerative diseases, focal epilepsy, and recovery after ischemic stroke. fMRI is also used for the presurgical localization of motor and language function.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite
700 1 _ |a Teipel, Stefan
|0 P:(DE-2719)2000026
|b 1
|u dzne
700 1 _ |a Hellwig, Sabine
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Langner, Sönke
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Rijntjes, Michel
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Klöppel, Stefan
|0 P:(DE-2719)9002559
|b 5
700 1 _ |a Weiller, Cornelius
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Meyer, Philipp T.
|0 P:(DE-HGF)0
|b 7
909 C O |o oai:pub.dzne.de:280934
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2000026
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21